Cleared Traditional

K250292 - OSPREY Midline Closed IV Catheter System (OspreyEDC-F20) (FDA 510(k) Clearance)

May 2025
Decision
91d
Days
Class 2
Risk

K250292 is an FDA 510(k) clearance for the OSPREY Midline Closed IV Catheter System (OspreyEDC-F20). This device is classified as a Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (Class II - Special Controls, product code FOZ).

Submitted by Skydance Vascular, Inc. (Pleasant Grove, US). The FDA issued a Cleared decision on May 2, 2025, 91 days after receiving the submission on January 31, 2025.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5200.

Submission Details

510(k) Number K250292 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2025
Decision Date May 02, 2025
Days to Decision 91 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code FOZ - Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5200

Similar Devices - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 14
BD Saf-T-Intima™ Subcutaneous Catheter System
K251422 · Becton Dickinson Infusion Therapy Systems, Inc. · Oct 2025
BD Nexiva™ Closed IV Catheter System
K243403 · Becton Dickinson Infusion Therapy Systems, Inc. · Jul 2025
BD Cathena™ Safety IV Catheter
K251155 · Becton Dickinson Infusion Therapy Systems, Inc. · Jul 2025
BD Insyte™ Autoguard™ Shielded IV Catheter, BD Insyte™ Autoguard™ BC Shielded IV Catheter and BD Insyte™ Autoguard™ BC Pro Shielded IV Catheter
K251654 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2025
BD Nexiva™ Diffusics™ Closed IV Catheter System and BD Nexiva™ Diffusics™ Closed IV Catheter System with BD MaxZero™ Needle-free Connector
K250682 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2025
Introcan Safety® 2 IV Catheter
K241845 · B.Braun Medical, Inc. · Jul 2024